Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2005 02:12 ET | Source: Crucell N.V.

Crucell Teams up with ACE BioSciences and Harvard to Accelerate Bacterial Antibody Program

LEIDEN, Netherlands, Nov. 02, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has licensed bacterial antigens from ACE BioSciences...
October 14, 2005 02:07 ET | Source: Galapagos Genomics

Galapagos Featured in Leading Drug Discovery Journal

MECHELEN, Belgium, Oct. 14, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces that an article presenting the Company's approach to target discovery will appear in...
September 30, 2005 02:35 ET | Source: Active Biotech

Active Biotech: Confirmed ANYARA Tumor PET Localization in Cancer Patients

STOCKHOLM, Sweden, Sept. 30, 2005 (PRIMEZONE) -- In an ongoing clinical Phase I study, specific tumor localization of Active Biotech's candidate drug ANYARA, has now been objectively confirmed.Using...
September 20, 2005 02:06 ET | Source: Crucell N.V.

Crucell Appoints Agents to Boost Asian Market Potential

LEIDEN, Netherlands, Sept. 20, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has entered into agreements with Pharma&Soft in...